Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.

dc.coverageDOI: 10.1007/s00198-019-05176-3
dc.creatorKanis, J. A.
dc.creatorHarvey, N. C.
dc.creatorMcCloskey, E.
dc.creatorBruyère, O.
dc.creatorVeronese, N.
dc.creatorLorentzon, M.
dc.creatorCooper, C.
dc.creatorRizzoli, R.
dc.creatorAdib, G.
dc.creatorAl-Daghri, N.
dc.creatorCampusano, C.
dc.creatorChandran, M.
dc.creatorDawson-Hughes, B.
dc.creatorJavaid, K.
dc.creatorJiwa, F.
dc.creatorJohansson, H.
dc.creatorLee, J. K.
dc.creatorLiu, E.
dc.creatorMessina, D.
dc.creatorMkinsi, O.
dc.creatorPinto, D.
dc.creatorPrieto-Alhambra, D.
dc.creatorSaag, K.
dc.creatorXia, W.
dc.creatorZakraoui, L.
dc.creatorReginster, J. Y.
dc.date2020
dc.date.accessioned05-01-2026 18:20
dc.date.available05-01-2026 18:20
dc.description<p>Summary: Guidance is provided in an international setting on the assessment and specific treatment of postmenopausal women at low, high and very high risk of fragility fractures. Introduction: The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2019. This manuscript seeks to apply this in an international setting, taking additional account of further categorisation of increased risk of fracture, which may inform choice of therapeutic approach. Methods: Clinical perspective and updated literature search. Results: The following areas are reviewed: categorisation of fracture risk and general pharmacological management of osteoporosis. Conclusions: A platform is provided on which specific guidelines can be developed for national use to characterise fracture risk and direct interventions.</p>eng
dc.descriptionGuidance is provided in an international setting on the assessment and specific treatment of postmenopausal women at low, high and very high risk of fragility fractures.spa
dc.identifierhttps://investigadores.uandes.cl/en/publications/c624ba42-56d7-42e6-85fd-4e44670930cc
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.31 (2020) date: 2020-01-01 nr.1 p.1-12
dc.subjectAnabolic agents
dc.subjectFRAX
dc.subjectFracture risk assessment
dc.subjectInhibitors of bone resorption
dc.subjectTreatment of osteoporosis
dc.subjectAnabolic agents
dc.subjectFracture risk assessment
dc.subjectFRAX
dc.subjectInhibitors of bone resorption
dc.subjectTreatment of osteoporosis
dc.subjectSDG 3 - Good Health and Well-being
dc.titleAlgorithm for the management of patients at low, high and very high risk of osteoporotic fractures.eng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections